Thomas Frinzi on professional endorsement
From STAAR Surgical CEO, Tom Frinzi Discusses Exciting Growth and Developments for 2023 · · EYE NEWS MEDIA
“We haven't had one ophthalmologist say to me that they aren't impressed with the quality and vision that the EVO ICL produces.”
On , Thomas Frinzi, Advisor at STAAR SURGICAL CO, spoke about professional endorsement during STAAR Surgical CEO, Tom Frinzi Discusses Exciting Growth and Developments for 2023 on EYE NEWS MEDIA.
About Thomas Frinzi
In a September 2023 interview, Thomas Frinzi, Chair of the Board, President and CEO of STAAR Surgical, discussed the company's recent performance and developments. He stated that the company had a strong first quarter with 20 percent growth globally, noting that China, a major market, had recovered from a dip in late 2022, and that the U.S. market grew by 78 percent year over year. Frinzi said the company had invested in its U.S. team by adding practice development personnel, clinical applications staff, territory managers, and new executives, which he described as raising the quality of the team. Frinzi attributed increased adoption of the EVO ICL lens to expanded digital marketing and direct-to-consumer advertising, as well as the procedure's simplification due to the elimination of the peripheral iridotomy. He cited 99.4 percent patient satisfaction and two million implants worldwide, adding that no ophthalmologist had expressed dissatisfaction with the lens's quality of vision. Frinzi described the current period as an exciting time to be associated with STAAR Surgical.